PYRIMIDINHYDRAZIDFORBINDELSER I DERS EGENSKAB AF PGDS-INHIBITORER
This invention is directed to a compound of formula (I): wherein R1, R2, R3, R4 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma an...
Saved in:
Main Authors | , , , , , , , , , , , |
---|---|
Format | Patent |
Language | Danish |
Published |
15.04.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | This invention is directed to a compound of formula (I): wherein R1, R2, R3, R4 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD). |
---|---|
AbstractList | This invention is directed to a compound of formula (I): wherein R1, R2, R3, R4 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD). |
Author | FENNIE, MICHAEL, W JOHN, STANLY SABOL, JEFFREY, S STOKLOSA, GRZEGORZ, T PRIBISH, JAMES, R PEDGRIFT, BRIAN THURAIRATNAM, SUKANTHINI MU, LAN ALDOUS, SUZANNE, C JIANG, JOHN, Z RAUCKMAN, BARBARA VANDEUSEN, CHRISTOPHER, L |
Author_xml | – fullname: STOKLOSA, GRZEGORZ, T – fullname: JIANG, JOHN, Z – fullname: FENNIE, MICHAEL, W – fullname: MU, LAN – fullname: PEDGRIFT, BRIAN – fullname: THURAIRATNAM, SUKANTHINI – fullname: VANDEUSEN, CHRISTOPHER, L – fullname: PRIBISH, JAMES, R – fullname: RAUCKMAN, BARBARA – fullname: SABOL, JEFFREY, S – fullname: ALDOUS, SUZANNE, C – fullname: JOHN, STANLY |
BookMark | eNrjYmDJy89L5WRwDIgM8vT1dPH084h0CXKM8nRx8w9y8vRzcfUJdg1S8FRwcQ0KVnB1d_UL9nZ0UnB0UwhwdwnWBSr3dPIM8Q9yDeJhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfEu3kaGJkamhmYhIcbGxKgBAB5nLUs |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | DK2142516TT3 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_DK2142516TT33 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:56:19 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | Danish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_DK2142516TT33 |
Notes | Application Number: DK20080744426T |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130415&DB=EPODOC&CC=DK&NR=2142516T3 |
ParticipantIDs | epo_espacenet_DK2142516TT3 |
PublicationCentury | 2000 |
PublicationDate | 20130415 |
PublicationDateYYYYMMDD | 2013-04-15 |
PublicationDate_xml | – month: 04 year: 2013 text: 20130415 day: 15 |
PublicationDecade | 2010 |
PublicationYear | 2013 |
RelatedCompanies | SANOFI |
RelatedCompanies_xml | – name: SANOFI |
Score | 2.8860128 |
Snippet | This invention is directed to a compound of formula (I): wherein R1, R2, R3, R4 and L1 are as defined herein, a pharmaceutical composition comprising the... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | PYRIMIDINHYDRAZIDFORBINDELSER I DERS EGENSKAB AF PGDS-INHIBITORER |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20130415&DB=EPODOC&locale=&CC=DK&NR=2142516T3 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ7UatSbVk2tj2BiuG3kUagXYoCFgqRAKJrWSwMLTXqhjcX49x02Rb3obbO7mcxu8s1rd2YA7jWmsybzjOhqrhO0_wuSyfmSFLrKlFJhoxF_aJ-EuvcyfJ5psw6s2lwYXif0kxdHREQxxHvN5fXmJ4hF-d_K7UO-wqn1k5saVNx5xyiQUSGJ1DKcOKKRLdq2QQMxTIymspgm66m6B_toRY8aMDivVpOUsvmtUdwTOIiRWFWfQqfIenBkt43XenA42b1343AHve0ZmPE8QUFD_dCb08R88yn6b5Yf0iZelAi-0CQLCM7YCaeBaQmmK8RjOiW43bf8NEqc5BzuXCe1PYK8LL7PvaBBy3WqqhfQrdZV2QchV5YKKwtJLh7LYZajh8MUNcvkAuFaSky6hMHfdAb_LV7BscK7PQyJrF1Dt37_KG9Q59b5Lb-tLwQ2gIs |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT4MwEL_MaZxvOjU6vzAxvDUOGMwXYoDCqGyMMDTbXhYoLNnLtjiM_75Hs6kv-ta0zeXa5Hdf7d0BPOjc4FXmGTG0zCBo_-ckVbI5yQ2Nq4XKu13x0D4IDf-18zLWxzVY7HJhRJ3QT1EcERHFEe-lkNfrnyAWFX8rN4_ZAqdWz15iUnnrHaNARoUkU9t0oyEdOrLjmDSQw9isKovpipFoe7CPFna3AoP7ZldJKevfGsU7hoMIiS3LE6jlaRMazq7xWhMOB9v3bhxuobc5BSuaxChoKAv9CY2tKaPov9kspFW8KJaYVCULSG7PDUeBZUuWJ0U9OiK4ndksGcZufAb3nps4PkFeZt_nntFgx3WiaedQX66WxQVImTpXeZG3lfyp6KQZejhc1dJUyRGuRZu3L6H1N53Wf4t30PCTQX_WZ2FwBUeq6PzQIYp-DfXy_aO4Qf1bZrfi5r4AN0CDfg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=PYRIMIDINHYDRAZIDFORBINDELSER+I+DERS+EGENSKAB+AF+PGDS-INHIBITORER&rft.inventor=STOKLOSA%2C+GRZEGORZ%2C+T&rft.inventor=JIANG%2C+JOHN%2C+Z&rft.inventor=FENNIE%2C+MICHAEL%2C+W&rft.inventor=MU%2C+LAN&rft.inventor=PEDGRIFT%2C+BRIAN&rft.inventor=THURAIRATNAM%2C+SUKANTHINI&rft.inventor=VANDEUSEN%2C+CHRISTOPHER%2C+L&rft.inventor=PRIBISH%2C+JAMES%2C+R&rft.inventor=RAUCKMAN%2C+BARBARA&rft.inventor=SABOL%2C+JEFFREY%2C+S&rft.inventor=ALDOUS%2C+SUZANNE%2C+C&rft.inventor=JOHN%2C+STANLY&rft.date=2013-04-15&rft.externalDBID=T3&rft.externalDocID=DK2142516TT3 |